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Alzheimer’s disease (AD) and type 2 diabetes are connected in a way that is still not completely understood, but insulin resistance
has been implicated as a risk factor for developing AD. Here we show an evidence that insulin is capable of reducing cytotoxicity
inducedbyAmyloid-betapeptides(A-beta)initsoligomericforminadose-dependentmanner.ByTUNELandbiochemicalassays
we demonstrate that the recovery of the cell viability is obtained by inhibition of intrinsic apoptotic program, triggered by A-beta
and involving caspase 9 and 3 activation. A protective role of insulin on mitochondrial damage is also shown by using Mito-red
vital dye. Furthermore, A-beta activates the stress inducible Hsp70 protein in LAN5 cells and an overexpression is detectable after
theaddition of insulin,suggestingthat thismajor induction isthenecessaryconditiontoactivate acell survivalprogram.Together,
these results may provide opportunities for the design of preventive and therapeutic strategies against AD.
1.Introduction
Alzheimer’s disease (AD) is the most common form of
dementia in the elderly. It is characterized by neuronal cell
loss and progressive accumulation of neuroﬁbrillary tangles
(NFT) in neurons, and amyloid ﬁbers in neuritic (senile)
plaques and in the walls of blood vessels [1]. This phys-
iopathological disorder causes a gradual loss of memory and
judgment. As the disease progresses, AD patients experience
changes in personality, behavior, and social interactions.
Amyloid beta peptide (A-beta) is the major component
ofamyloidplaquesinthebrainofindividualsaﬀectedbyAD.
The formation of the plaques is due to an overproduction
of A-beta through enzymatic cleavage of the larger amyloid
proteinprecursor(APP).WhilethemonomericA-betaisnot
neurotoxic, under speciﬁc conditions it is able to misfold
from its soluble form into small oligomers and highly
ordered ﬁbrillar aggregates. This phenomenon is known as
the aggregation of proteins and it is a characteristic feature
of several neurodegenerative diseases [2]. Although neuronal
degeneration occurs near the amyloid plaques, some studies
have suggested that intermediates such as protoﬁbrils or
simple oligomers are also involved in AD pathogenesis and
even appear to be the more dangerous species in the onset of
the pathology [3].
Genetic researches have demonstrated that only a small
fraction (about 5%) of all AD cases is caused by inherited
alterations with precocious symptom appearance (before age
65) [4]. The early AD onset is, in most cases, originated by
mutations in three genes: APP, PSEN1, and PSEN2. As a
result, a large amount of A-beta toxic fragments is produced
anddepositedasplaques.ThegreatmajorityofallADcasesis
sporadic in origin, with old age (>65) as the main risk factor.
The “amyloid cascade hypothesis” has tried to explain
the origin of the disease. This theory postulates that the
deposition of A-beta is the origin of the pathology and that
cell loss, dementia, and vascular damage are strictly linked
with this deposition. This hypothesis can give an explanation
for the AD early onset but it is not viable for the AD sporadic
form. Indeed, patients aﬀe c t e db yA Dl a t e - o n s e tv e r yr a r e l y2 Journal of Biomedicine and Biotechnology
present APP, PSEN1, and PSEN2 gene mutations. Further,
thepresenceoftheplaquescanalsobeobservedintheelderly
without AD development [5].
Type 2 diabetes is associated to a reduced ability of
insulin to stimulate glucose utilization (insulin resistance).
It has been recently recognized that AD is closely linked to
the diabetes mellitus in a way that it is still unclear and a
deﬁciencyintheglucosemetabolismcanbeconsideredarisk
factor in the sporadic AD onset [6–8]. Further some diabetes
drugsappeartoslowthecognitivedeclineassociatedwithAD
[9].Ithasbeen also demonstratedthatextracellularinjection
of insulin is able to protect neurons against A-beta induced
cell death [10].
Ithasbeenreported[11]thatinsulincanprotectcultured
rat neurons against A-beta induced toxicity. Experimental
data [12] have demonstrated that A-beta competes for
binding of insulin to its receptor. This results in a decrease
in autophosphorylation of the insulin receptor. However,
it is not understood if this eﬀect was originated through
the binding of A-beta to insulin or directly to the insulin
receptor. By using mature cultures of hippocampal neurons
it was found that A-beta soluble oligomers (also known as
ADDLs) caused loss of the activation of insulin receptors
(IR) on the neuronal surface, and this event was linked to
disruption of insulin signaling [13]. Other studies indicate
that insulin, interacting with A-beta, inhibits its ﬁbrillar
growth as shown in a cell-free assay and in the cell surface of
human brain pericytes [10] reducing the A-beta toxic eﬀect.
Recently, in two diﬀerent model systems, sea urchin
embryo and neuroblastoma cell line, it has been demon-
strated that A-beta oligomers are more toxic than larger and
highly structured ﬁbrils [14, 15]. In particular, oligomers
and ﬁbrils, involved in the neurodegenerative process are
able to induce two diﬀerent apoptotic pathways [15]. The
authors postulate that the large ﬁbrils, remaining on the
extracellularspaceandobstructingthemembranefunctional
channels, can induce an extrinsic programmed cell death
pathways through the activation of caspase 8 only. On the
contrary, the small oligomers are able to penetrate into the
cells.They,damagingthemitochondria,causeareleaseofthe
cytochromeCthat,inturn,inducesactivationoftheintrinsic
apoptotic pathway by the intervention of the caspase 9.
The present study is addressed to investigate whether
insulin is able to protect cells by A-beta oligomers toxicity,
through inhibition of speciﬁc apoptotic pathways activation.
2.MaterialsandMethods
2.1. Cell Cultures and Treatments. LAN5 human neuroblas-
toma cell lines were plated onto 96-well plates at a density
of 6 × 104 per well and cultured with RPMI 1640 medium
(CELBIO) supplemented with 10% fetal bovine serum
(FBS) (GIBCO) and 1% antibiotics (50μ/mL penicillin and
50μg/mL streptomycin) and antimycotics (SIGMA). Cells
weremaintained inhumidiﬁed 5%CO2 atmosphereat37◦C.
In order to obtain the oligomers, recombinant Aβ42
(rAβ42) was dissolved in 0.01M TrisHCl buﬀer at pH 7.2
[14] and insulin (SIGMA) in HEPES buﬀer at pH 8.2.
Cells were treated with two diﬀerent concentrations 25
and 40μM of oligomeric rAβ42 [14] for 1 h. After this
treatment rAβ42 was removed and the cell were incubated
without or with insulin at diﬀerent concentrations (50,
100, 200μM) in medium serum free at 37◦Cf o r2 0h .
For successive experiments we selected the A-beta oligomer
and insulin concentrations at 40 and 100μM, respectively.
In caspase assays, the incubation time with insulin was
4 h. The treated cultured cells and the controls were
morphologically analysed by microscopy inspection using
an Axioscop 2 microscope (Zeiss, USA) or used for speciﬁc
assays. Depending on the experiments we also utilized, as
controls, both the untreated cells and the cultured cells with
buﬀers at the concentration utilized to dissolve rAβ42 or
insulin.
2.2. Determination of Cell Viability. Cell viability was
measured by MTS assay (PROMEGA). MTS [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfopheyl)2H-tetrazolium] was utilized according to the
manufacturer’s instructions. After treatments of the cells,
20μL of the MTS solution were added to each well, and
the incubation was prolonged for 4 h at 37◦C, 5% CO2.
The absorbance was read at 490nm on the Microplate
reader
wallac
Victor
2 1420 MULTILABEL COUNTER (Perkin
Elmer). Results were expressed as the percentage of MTS
reduction as regard to the controls.
2.3. Apoptosis Assay. TUNEL assay was performed according
to the manufacturer instructions (PROMEGA). Brieﬂy, cells
untreatedoraftertreatmentwithrAβ42aloneorwithinsulin
were ﬁxed with 4% paraformaldehyde in PBS for 30 min.
Then they were washed with PBS, permeabilized with 0.2%
Triton X-100 in PBS for 5 min, rinsed with PBS and incu-
bated with TUNEL reaction mixture (enzyme, nucleotides)
inanhumidiﬁedatmosphereat37◦Cfor1hour.Stainingwas
obtained by using a peroxidase substrate, hydrogen peroxide
and the stable chromogen, diaminobenzidine (DAB). After
thisprocedure,sampleswererinsedthreetimeswithPBSand
analysed under Zeiss Axioscop microscope.
2.4. Mitochondrial and Nuclear Staining. O n ev i a lo fM i t o
red was dissolved in DMSO according to the manufacturer
instructions (SIGMA). Living cells were incubated with
20nM Mito red for 5 min and red staining indicates
that the mitocondrial is active. For nuclear staining, cells
were incubated in the Hoechst 33258 (5μg/mL) for 30
min and intense blue staining indicates nuclear fragmenta-
tion. Nuclear morphology and mitochondrial activity were
analyzed by microscopic inspection using a Leica DHL
ﬂuorescentmicroscopeatexcitation/emissionwavelengthsof
350/450nm, respectively.
2.5. Caspase Assays. Caspase-8, -9, and -3 activities in cells
were measured using commercially available luminescent
assays (caspase-Glo 8, caspase-Glo 9 and caspase-Glo 3/7
assay systems, PROMEGA). LAN5 cells were treated with
oligomers alone or with insulin. LAN5 cells untreated orJournal of Biomedicine and Biotechnology 3
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Figure 1: Dose dependence of protective eﬀect of insulin against rAβ42 oligomers induced cell death. (a) LAN5 neuroblastoma cells were
untreated (control) or incubated with insulin 50 or 100 or 200μM of insulin alone or after incubation with 25 or 40μMo fr A β42. After
incubation treated and untreated cells were submitted to viability MTS assay. Cell viability is signiﬁcantly lower in rAβ42 25μM
∗P <. 01,
rAβ4225μM+insulin50μM
∗P <. 01versuscontrol,whereasitisnotsigniﬁcantlylowerwithrAβ4225μM+insulin100μMversuscontrol.
Cell viability is signiﬁcantly lower in rAβ42 40μM
∗P <. 003, rAβ42 40μM + insulin 50μM
∗P <. 003, whereas it is not signiﬁcantly lower
with Aβ 40μM + insulin 100μM versus control. Percentage of viability is referred to control, the data are the mean ± SD of three separate
experiments. (b) Representative morphological images of LAN5 untreated cells (control), treated with rAβ42 40μM, rAβ42 40μM, and
insulin 100μM, insulin alone 100μM. Bar 20μm.
treated with insulin alone were used as control. Caspase
reagent speciﬁc for each kit was added directly to the
cells in white 96-well plates and after mixing, they were
incubatedfor15–30minbeforerecordingluminescencewith
wallac
Victor
2 1420 MULTILABEL COUNTER (Perkin Elmer)
apparatus. The caspase activator assay was performed using
50μM vinblastine (SIGMA).
2.6. Protein Extraction and Western Blotting. Total proteins
were prepared by dissolving in solubilizing buﬀer (50mM
Tris-HCl pH 8.0, 150mM NaCl, 0.5% Triton X-100, 2mM
PMSF, 10μg/mL protease inhibitor, 1mM Na3VO4,a n d
1mM NaF) LAN5 cells untreated (control) or treated with
oligomers, alone or with insulin. Protein samples (20μg)
were electrophoretically separated using 10% SDS-PAGE gel
and transferred onto nitrocellulose ﬁlters for immunoblot-
ting. After blocking in 3% BSA in TBST, the Western
blot was incubated with antiphosphorylated Hsp70 (Hsp70)
(1:1000; Cell Signalling) or anticonstitutive Hsp70 (Hsc70)
(1:500; Cell Signalling) or anti β-actin (1:1000). Primary
antibodies were detected using the ECL chemiluminescence
kit(Amersham)accordingtothemanufacturer’sinstructions
and using secondary antibodies conjugated to horseradish
peroxidase (1:1500; Amersham). Band intensities were
analyzed with a gel documentation system (BioRad). Hsp70
and Hsc70 expression were adjusted to β-actin expression.
The protein levels were expressed as densitometry.
2.7. Statistical Analysis. All experiments were repeated at
least three times. Each experiment was performed in trip-
licate. The results are presented as mean ± SD. Statistical
evaluation was conducted by ANOVA, followed by Student’s
t-test for analysis of signiﬁcance. P<. 05 was considered
statistically signiﬁcant.
3. Results
3.1. Insulin Protects Neuroblastoma Cells against rAβ42
Oligomers Toxicity. As a ﬁrst step to evaluate the amount
of insulin necessary to interfere with cell damage induced
by A-beta oligomers, a dose-response study was performed.
LAN5 neuroblastoma cells were treated before with diﬀerent
amounts of rAβ42 oligomers (25, 40μM) and then with
diﬀerent insulin concentrations (50, 100, 200μM).
As shown in Figure 1(a), cells treated with rAβ42, 25μM
or 40μM showed a mortality of about 60% and 85%,4 Journal of Biomedicine and Biotechnology
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Figure 2: Protective eﬀect of insulin against rAβ42 oligomers
induced apoptosis. LAN5 untreated cells as control (a), treated with
rAβ42 oligomers (40μM) for 1 h (b), with rAβ42 (40μM) for 1 h
and with insulin (100μM) for 20 h (c), insulin alone (100μM) for
20 h (d) were ﬁxed and put through TUNEL assay. Bar 20μm.
respectively, if compared to the control. When insulin was
added, in the sample previously treated with oligomers,
a recovery of cell viability of about 20% for the minor
concentration and 100% for the higher concentration was
observed, indicating that insulin plays a protective eﬀect
against A-beta toxicity (Figure 1(a)).
Moreover,tovisualizetheresultsobtainedbytheviability
assay, the morphological eﬀect compared to the correspond-
ing controls was examined by microscopic inspection. Neu-
rons treated with rAβ42 oligomers at diﬀerent degeneration
steps were observed and some representative images are
shown in Figure 1(b). Morphological changes resulted in a
reduction of the cellular body, neuritis, and cell numbers.
Cells treated with rAβ42 oligomers and insulin appeared to
recover the regular morphology of neurons.
3.2. Insulin Reduces Apoptosis Induced by rAβ42 Oligomers.
In apoptosis a biochemical cascade activates proteases that
destroy biomolecules required for cell survival. During
this process the cytoplasm condenses, organelles aggregate,
chromatin condenses, and nucleus fragments [16]. After cell
treatment with rAβ42 oligomers, we detected in the sur-
vived cells morphological modiﬁcations, typical hallmarks
of the apoptosis process. In particular granules, resembling
apoptotic bodies, were observable (data not shown). To
investigate if insulin can revert this eﬀect, LAN5 cells were
put through to the TUNEL assay after treatment with
oligomers alone or with oligomers and insulin. An intense
brown nuclear staining is visible in the cells treated with
rAβ42 (Figure 2(b)), indicating that the apoptotic process
has been triggered, whereas no staining is detectable in the
cells treated with oligomers and insulin (Figure 2(c)), as seen
for the control cells (Figures 2(a) and 2(d)).
3.3. Insulin Inhibits Intrinsic Apoptotic Pathway Induced by
rAβ42 Oligomers. The major executioners in the apoptotic
program are proteases known as caspases. In some forms
of apoptosis, the extrinsic apoptotic pathway is initiated
by activation of caspase 8 after death receptor binding; in
other forms, activation of the intrinsic apoptotic pathway is
initiated by signaling molecules, recruited by mitochondria.
They lead a release of cytochrome C from mitochondrial
matrix to cytoplasm where it binds to Apaf-1 protein to form
the apoptosome that activates caspase 9 [16]. Both these
pathways are able to activate the executrix caspase-3 involved
in the ﬁnal part of death process. To identify in which rAβ42-
oligomer induced apoptotic pathway insulin interferes, we
performed caspase 8 and caspase 9 luminometric assays. A
caspase activator was employed as a control. According to
previous results, no activation of capsase 8 by oligomers
stimulus occurred [15] and the same result for insulin
stimulus was obtained (Figure 3(a)). Instead, as can be seen
in Figure 3(b), A-beta oligomers activate caspase 9 and this
activation is noticeably reduced by the presence of insulin,
indicating, once again, that insulin is able to produce a
positive protective eﬀect. In order to conﬁrm this result,
LAN5 cells treated as described above were put through to
caspase 3 assay, the typical executrix caspase. As expected,
in the LAN5 cells treated with oligomers and insulin a
reduction in the caspase 3 activation with respect to the
A-beta oligomer treated cells was detected (Figure 3(c)).
These results conﬁrm that A-beta oligomers induce intrinsic
apoptotic pathway and the insulin is able to down-regulate
caspases 9 and 3 activation.
3.4. Insulin Recovers Mitochondrial Respiratory Activity
Reduced by rAβ42 Oligomers. Caspase 9 activation is con-
sidered an event subsequent to mitochondrial damage. In
ordertoconﬁrmthatadysfunctionofthisorganelleoccurred
after A-beta stimulus and this dysfunction is replaced or
avoidedbyinsulintreatment,wetestedthemetabolicactivity
of the mitochondria by using Mito red, a speciﬁc dye
that permits to measure the respiratory activity. Once the
dye is introduced into the cells, it freely diﬀuses through
the outer mitochondrial membrane and enters exclusively
into the mitochondrial matrix of the metabolically active
mitochondrials. The red staining, shown in Figure 4, indi-
cates mitocondrial activity. Moreover, the nucleus integrity
was visualized by staining the samples with the speciﬁc
Hoechst dye. In Figure 4 an intense red staining, comparable
to the control cells, was observed in cell treated with A-
beta oligomers and insulin and no intense blue staining,
indicating nuclear fragmentation, was observed. In contrast,
absence of red staining is visible in the cells treated with
A-beta oligomers alone, while an intensive blue staining
is evident, stating the presence of DNA nicks, a typical
apoptosis hallmark. This analysis conﬁrms that the rAβ42
induced degeneration, via mitochondrial damage, has been
counteracted by insulin addition.
3.5. Modulation of Stress Response Activation. Hsp70 has
a negative regulatory role in apoptosis and is activated,
by phosphorylation process, in response to a variety ofJournal of Biomedicine and Biotechnology 5
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Figure 3: Eﬀects of insulin against rAβ42 oligomers on caspase
9 and 3 activation. LAN5 were untreated (control), treated with
rAβ42oligomers(40μM)for1h(rAβ42),rAβ42oligomers(40μM)
for 1 h and insulin (100μM) for 4 h (rAβ42 + insulin), insulin
alone (100μM) for 4 h (insulin), 50μM Vinblastine for 4 h
(activator) and submitted to caspase 8 (a), caspase 9 (b), and
caspase 3 (c) luminescent assays. Data expressed as percentage of
the corresponding control. The dashed line shown in the histogram
corresponds to a control culture. The activation of caspase 8 (a)
is signiﬁcantly high with activator
∗P <. 02, whereas it is not
signiﬁcantly high in rAβ42 versus control. The activation of caspase
9 (b) is signiﬁcantly high in rAβ42
∗P <. 0 1a n di nt h ea c t i v a t o r
∗P <. 05, whereas it is not signiﬁcantly high in rAβ42 + insulin
versus control. The activation of caspase 3 (c) is signiﬁcantly high
in rAβ42
∗P <. 01 and in the activator
∗P <. 01, whereas it is
not signiﬁcantly high in rAβ42 + insulin versus control. Values are
referred to control, the data are the mean ± SD of three separate
experiments.
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Figure 4: Insulin recovers mitochondrial respiratory activity,
reduced by rAβ42 oligomers. LAN5 were untreated (control),
treated with rAβ42 oligomers (40μM) for 1 h (oligomers), rAβ42
oligomers (40μM) for 1 h and insulin (100μM) for 20 h (oligomers
+ insulin). Cells were incubated with Mito Red and Hoechst 33258.
The images of each sample were merged. Red staining indicates
mitochondrial activity (see red arrows). Blue staining indicates
nuclear fragmentation (see blue arrows).
stress stimuli. To test whether the insulin can play its
protective role by activating or improving activation of
Hsp70, a Western blot experiment was performed. Same
amounts of proteins extracted from cells, (i) untreated,
(ii) A-betatreated, (iii) treated with insulin alone, and (iv)
previously treated with A-beta, were loaded on a SDS-
PAGE. The immunoblot was incubated with antibodies
against both the constitutive and inducible Hsp70 stress
proteins and antiβactin for normalizing gel loading. Levels
of the constitutively expressed Hsp70 form (Hsc70) do not
change after any stimulus. In agreement with other studies
[17], A-beta presence increased the Hsp70 stress-inducible
form (Hsp70) as compared with the control (Figure 5). In
contrast no activation was detected when LAN5 cells were
incubated with insulin alone. Moreover, insulin enhanced A-
beta mediated activation of Hsp70 suggesting that this major
induction could be necessary to complete a cell survival
program.
4. Discussion
An increasing number of reports suggest that A-beta
accumulates inside neurons with aging and that A-beta6 Journal of Biomedicine and Biotechnology
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Figure 5: Insulin enhances inducible Hsp70 activation triggered by
rAβ42 oligomers. Western blot of proteins extracted from LAN5
untreated (1), treated with rAβ42 oligomers (40μM) for 1 h (2),
rAβ42 oligomers (40μM) for 1 h and insulin (100μM) for 20 h (3),
insulinalone(100μM)for20h(4),incubatedwithanticonstitutive
Hsp70 (Hsc70), antiinducible Hsp70 (Hsp70) or beta-actin (β-
actin). Uniformity of gel loading was conﬁrmed with β-actin as
standard. Quantiﬁcation of immunoreactivity was performed using
densitometric analysis.
aggregation can be an initial event for the characteristic cell
degeneration present in the Alzheimer’s pathology. A-beta
aggregatedmoleculesalternormalcellhomeostasisincluding
impaired glucose/energy metabolism, mitochondrial dys-
function and oxidative stress [18]. Recently, several studies
suggest that disturbance in insulin metabolism, especially
insulin resistance, plays a role in the onset and development
of AD. Thus, growing evidence begins to ﬁnd links between
AD and type 2 diabetes and, for this reason, AD has
been considered the “brain-type diabetes” [5, 19]. Here
we provide evidence that insulin can protect cells against
damage induced by A-beta oligomers avoiding the apoptosis
program.
We found that insulin inhibits A-beta cell death in LAN5
neuroblastoma cells in a dose-dependent manner. According
to several results diﬀerent are the hypothesis reported to
explain a mechanism underlying the protective role played
by insulin to contrast the impairment produced by A-beta
oligomers. Among the ﬁrst studies, it has been demonstrated
thatspeciﬁcallydibutyrylcAMPorinsulininhibittoxiceﬀect
of A-beta22–35 in cultured rat hippocampal neurons and a
recover of the intracellular signal transduction disorder was
suggested [11]. More recently, on the basis that A-beta and
insulin are both amyloidogenic peptides sharing a common
sequence recognition motif [20], it has been reported that A-
beta hinders the insulin binding to its receptor (IR), leading
to an IR reduced autophosphorylation [12]. The authors
suggest that the link between A-beta and insulin is associated
to the impairment of glucose utilization, and in agreement
to this hypothesis, a recovery of cell viability, through insulin
administration could be due to the retrieval of normal
glucose metabolism. Other authors [10] suggest that insulin
inhibits A-beta ﬁbril network formation, an essential step
in exerting its toxicity, at the cell surface of human brain
pericytes (HBP). In fact, the HBP line does not express IR,
therefore in this case the protective eﬀect of insulin can
not be due to its reduced binding to IR. All the results
reported above underline that insulin is able to recover
an intracellular damage induced by A-beta, whose eﬀect
is to produce cellular stress and degeneration. Apoptosis
has been often associated to neurodegeneration [21]a n d
to ﬁnd a mechanism that control caspase activation could
be a promising approach to hinder the cell death process.
By speciﬁc assays, we demonstrate that insulin opposes
to apoptotis and particularly caspase 9 and 3 activation
after A-beta induced toxicity. According to previous results
caspase 8 was not activated by A-beta oligomers, because the
extrinsic pathway is a preferential process activated by larger
A-beta ﬁbrils [15]. Caspase 9 activation is a consequence
of mitochondrial dysfunction often provoked by oxidative
stress, and increased oxidative stress has been implicated
in the etiology of several pathology including diabetes and
AD [22, 23]. Mitochondria are both the major generators
and direct targets of reactive oxygen species (ROS) and this
had led to the idea that oxidative stress and mitochondrial
damage are contributory factors to several disorders. More-
over, it has been demonstrated that, in the presence of A-
beta, insulin prevents the decline in mitochondrial oxidative
phosphorylation eﬃciency and avoids an increase in oxida-
tive stress [24]. These data are in agreement with the result
here shown that the mitochondrial activity is impaired when
the neuroblastoma cells are treated with A-beta oligomers
and that this eﬀect is recovered when insulin is added.
Moreover, insulin prevents apoptotic pathway activation as
observable by the absence of nuclear fragmentation, that
instead is well evident in the oligomers treated cells. Thus,
we suggest that insulin prevents mitochondrial dysfunction
probably by inhibition of ROS formation and activating
speciﬁc cell signaling (work in progress). Further, it is known
that insulin activates the serine-threonine kinase Akt, a
protein downstream of PI3K, involved in survival pathway
[25–27]. Akt has been well demonstrated to phosphorylating
and increasing the expression of a number of proteins
involved in apoptotic signaling cascade such as the Bcl-
2f a m i l y[ 28, 29]. Presence of A-beta produces a toxic
eﬀect, responsible for the observed neuron death. SomeJournal of Biomedicine and Biotechnology 7
evidences point out the role of molecular chaperones in
neurodegenerative processes [30, 31]. We show that a stress
response is activated by the increased expression of inducible
Hsp70. Interestingly, A-beta is able to activate Hsp70 but, in
the present experimental conditions, the endogenous stress
response is insuﬃcient to revert the apoptotic pathway.
Upregulation of Hsp70 has been found in neurons treated
with A-beta and a modulator role in A-beta toxicity has been
proposed [17]. The authors hypothesize that an imbalance
between the neuronal Hsp protective capacity and the toxic
accumulation of A-beta could be the cause of the neuronal
death. The presence of insulin enhances the activation of the
stressproteins,suggestingthatanincreasedsurvivalprogram
has been activated and the neurons recover their viability.
Moreover, it has been demonstrated that Hsp70 is induced
by PI3/Akt activation [32] that in turn is activated by insulin.
Heat shock proteins can neutralize the neurotoxicity in
animal models suggesting potential therapeutic approaches
in neurodegeneration associated with abnormal folding and
toxicity [33, 34]. Other observations have demonstrated
the presence of Hsp70 in AD brain [35]. Hsp70 plays a
role in preventing protein aggregation and degradation [36,
37]. Helped by insulin, that increases its expression and
activation, we can assume that Hsp70 could prevent A-
beta oligomers by successive aggregation steps or promote
oligomers degradation.
5. Conclusions
The present data point out the protective action of insulin
in inhibiting A-beta cell toxicity and they could be an initial
step to understand as insulin resistance or disturbance in
insulin metabolism can contribute to neurodegeneration.
Moreover, insulin may constitute a therapeutic agent against
AD, activating cell survival signaling pathways.
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